PTN
Companies
Nyse American
Palatin Technologies Inc.
Health Care
$0.15
-$0.96 (-86.67%)
Price Chart
Overview
About PTN
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.
Market Cap
$30.2M
Volume
164.6K
Avg. Volume
118.8K
P/E Ratio
0.2350532
Dividend Yield
0.00%
Employees
39.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.13
Moderate Correlation
Volatility
High (0.96)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PTN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$30.2M
Volume164.6K
P/E Ratio0.24
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025